Sebastian Oberbeck

Bonn, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dexamethasone induced Dectin-1 activation enhances NLRP3 inflammasome activation.

Dexamethasone induced Dectin-1 activation enhances NLRP3 inflammasome activation.

Journal: Frontiers in immunology

Published: June 29, 2025

CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity.

CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity.

Journal: Frontiers in immunology

Published: October 19, 2021

Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia.

Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia.

Journal: Cancer research

Published: June 16, 2021

Corrections: Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine.

Corrections: Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine.

Journal: Leukemia

Published: October 24, 2020

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.

Journal: Biomarker research

Published: September 05, 2020

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

Journal: Blood

Published: September 26, 2019

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine.

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine.

Journal: Leukemia

Published: July 30, 2019

Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses.

Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses.

Journal: Cancer immunology, immunotherapy : CII

Published: July 17, 2019

New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.

New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.

Journal: Leukemia & lymphoma

Published: September 21, 2018

Next-generation amplicon TRB locus sequencing can overcome limitations of flow-cytometric Vβ expression analysis and confirms clonality in all T-cell prolymphocytic leukemia cases.

Next-generation amplicon TRB locus sequencing can overcome limitations of flow-cytometric Vβ expression analysis and confirms clonality in all T-cell prolymphocytic leukemia cases.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: March 01, 2018

Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer.

Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer.

Journal: Cancer research

Published: July 19, 2017

Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.

Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.

Journal: Nature communications

Published: May 12, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026